{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:06:34Z","timestamp":1790431594134,"version":"4.1.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.1001\/jamacardio.2019.5586","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T16:39:42Z","timestamp":1579106382000},"page":"309","source":"Crossref","is-referenced-by-count":64,"title":["Long-term Cardiopulmonary Consequences of Treatment-Induced Cardiotoxicity in Survivors of <i>ERBB2<\/i>-Positive Breast Cancer"],"prefix":"10.1001","volume":"5","author":[{"given":"Anthony F.","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Flynn","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaya S.","family":"Moskowitz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"Oeffinger","sequence":"additional","affiliation":[{"name":"Duke Cancer Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau T.","family":"Dang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee W.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Steingart","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"},{"name":"Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"31","key":"hoi190099r1","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1200\/JCO.2011.40.0010","article-title":"Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.","volume":"30","author":"Romond","year":"2012","journal-title":"J Clin Oncol"},{"issue":"9897","key":"hoi190099r2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)61094-6","article-title":"2 years versus 1 year of adjuvant trastuzumab for HER2-positive breast cancer (HERA): an open-label, randomised controlled trial.","volume":"382","author":"Goldhirsch","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"hoi190099r3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cardfail.2011.10.015","article-title":"Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer.","volume":"18","author":"Tarantini","year":"2012","journal-title":"J Card Fail"},{"issue":"14","key":"hoi190099r4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer.","volume":"365","author":"Slamon","year":"2011","journal-title":"N Engl J Med"},{"issue":"25","key":"hoi190099r5","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1200\/JCO.2005.04.9551","article-title":"Long-term cardiac tolerability of trastuzumab in metastatic breast cancer: the MD Anderson Cancer Center experience.","volume":"24","author":"Guarneri","year":"2006","journal-title":"J Clin Oncol"},{"issue":"24","key":"hoi190099r6","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.jacc.2012.07.068","article-title":"Incidence of heart failure or cardiomyopathy after adjuvant trastuzumab therapy for breast cancer.","volume":"60","author":"Chen","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"hoi190099r7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jchf.2018.09.001","article-title":"Long-term risk of heart failure in breast cancer patients after adjuvant chemotherapy with or without trastuzumab.","volume":"7","author":"Banke","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"35","key":"hoi190099r8","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1200\/JCO.2017.74.1165","article-title":"Long-term follow-up of cardiac function and quality of life for patients in NSABP Protocol B-31\/NRG Oncology: a randomized trial comparing the safety and efficacy of doxorubicin and cyclophosphamide (AC) followed by paclitaxel with AC followed by paclitaxel and trastuzumab in patients with node-positive breast cancer with tumors overexpressing human epidermal growth factor receptor 2.","volume":"35","author":"Ganz","year":"2017","journal-title":"J Clin Oncol"},{"issue":"21","key":"hoi190099r9","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/eurheartj\/ehv510","article-title":"Beyond ejection fraction: an integrative approach for assessment of cardiac structure and function in heart failure.","volume":"37","author":"Cikes","year":"2016","journal-title":"Eur Heart J"},{"issue":"20","key":"hoi190099r10","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2011.39.9014","article-title":"Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.","volume":"30","author":"Jones","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10","key":"hoi190099r11","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3109\/0284186X.2014.899435","article-title":"Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy.","volume":"53","author":"Klassen","year":"2014","journal-title":"Acta Oncol"},{"issue":"22","key":"hoi190099r12","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1200\/JCO.2017.77.5809","article-title":"Efficacy of exercise therapy on cardiorespiratory fitness in patients with cancer: a systematic review and meta-analysis.","volume":"36","author":"Scott","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"hoi190099r13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lungcan.2011.10.009","article-title":"Prognostic significance of functional capacity and exercise behavior in patients with metastatic non\u2013small cell lung cancer.","volume":"76","author":"Jones","year":"2012","journal-title":"Lung Cancer"},{"key":"hoi190099r14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1477-7525-7-47","article-title":"Associations between cardiorespiratory fitness and health-related quality of life.","volume":"7","author":"Sloan","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"hoi190099r15","first-page":"535","article-title":"Is cardiorespiratory fitness related to quality of life in survivors of breast cancer?","volume":"20","author":"Herrero","year":"2006","journal-title":"J Strength Cond Res"},{"issue":"12","key":"hoi190099r17","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","article-title":"Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.","volume":"18","author":"Lang","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"hoi190099r18","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9363951","article-title":"Two-dimensional speckle tracking echocardiography detects subclinical left ventricular systolic dysfunction among adult survivors of childhood, adolescent, and young adult cancer.","volume":"2016","author":"Yu","year":"2016","journal-title":"Biomed Res Int"},{"issue":"4","key":"hoi190099r19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.echo.2018.12.009","article-title":"Assessment of early radiation-induced changes in left ventricular function by myocardial strain imaging after breast radiation therapy.","volume":"32","author":"Yu","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"hoi190099r20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/rccm.167.2.211","article-title":"ATS\/ACCP statement on cardiopulmonary exercise testing.","volume":"167","author":"American Thoracic Society","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"hoi190099r21","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-013-2818-1","article-title":"Utility of 3-dimensional echocardiography, global longitudinal strain, and exercise stress echocardiography to detect cardiac dysfunction in breast cancer patients treated with doxorubicin-containing adjuvant therapy.","volume":"143","author":"Khouri","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"hoi190099r22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.70.3.425","article-title":"Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window.","volume":"70","author":"Lewis","year":"1984","journal-title":"Circulation"},{"issue":"9","key":"hoi190099r23","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.","volume":"27","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"issue":"5","key":"hoi190099r24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","article-title":"Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity.","volume":"26","author":"Negishi","year":"2013","journal-title":"J Am Soc Echocardiogr"},{"issue":"7","key":"hoi190099r25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004661","article-title":"Additive prognostic value of left ventricular systolic dysfunction in a population-based cohort.","volume":"9","author":"Kuznetsova","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"hoi190099r26","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2019.2952","article-title":"Assessment of prognostic value of left ventricular global longitudinal strain for early prediction of chemotherapy-induced cardiotoxicity: a systematic review and meta-analysis.","author":"Oikonomou","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"19","key":"hoi190099r27","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.jacc.2018.08.2166","article-title":"Cardiorespiratory fitness and mortality in healthy men and women.","volume":"72","author":"Imboden","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"hoi190099r28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrclinonc.2014.127","article-title":"Cancer-related fatigue: mechanisms, risk factors, and treatments.","volume":"11","author":"Bower","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"hoi190099r29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/cncr.21671","article-title":"Fatigue in long-term breast carcinoma survivors: a longitudinal investigation.","volume":"106","author":"Bower","year":"2006","journal-title":"Cancer"},{"issue":"24","key":"hoi190099r30","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1161\/CIR.0000000000000461","article-title":"Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association.","volume":"134","author":"Ross","year":"2016","journal-title":"Circulation"},{"issue":"13","key":"hoi190099r31","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jacc.2014.07.949","article-title":"Unravelling the causes of reduced peak oxygen consumption in patients with cancer: complex, timely, and necessary.","volume":"64","author":"Koelwyn","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"hoi190099r32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ehjci\/jeu277","article-title":"Left ventricular global longitudinal strain is associated with exercise capacity in failing hearts with preserved and reduced ejection fraction.","volume":"16","author":"Hasselberg","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"hoi190099r33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1476-7120-11-20","article-title":"Speckle tracking echocardiography-determined measures of global and regional left ventricular function correlate with functional capacity in patients with and without preserved ejection fraction.","volume":"11","author":"Petersen","year":"2013","journal-title":"Cardiovasc Ultrasound"},{"issue":"7","key":"hoi190099r34","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002014","article-title":"Effects of exercise training on cardiorespiratory fitness and biomarkers of cardiometabolic health: a systematic review and meta-analysis of randomized controlled trials.","volume":"4","author":"Lin","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"hoi190099r35","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1158\/1055-9965.EPI-04-0703","article-title":"Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.","volume":"14","author":"Schmitz","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"hoi190099r36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1503\/cmaj.051073","article-title":"Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis.","volume":"175","author":"McNeely","year":"2006","journal-title":"CMAJ"},{"issue":"2","key":"hoi190099r37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pcad.2018.12.003","article-title":"The Association between the change in directly measured cardiorespiratory fitness across time and mortality risk.","volume":"62","author":"Imboden","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"hoi190099r38","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13971","article-title":"Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy.","volume":"7","author":"Beaudry","year":"2019","journal-title":"Physiol Rep"},{"issue":"10","key":"hoi190099r39","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1634\/theoncologist.12-10-1156","article-title":"Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor\u2013positive operable breast cancer.","volume":"12","author":"Jones","year":"2007","journal-title":"Oncologist"},{"key":"hoi190099r16","volume-title":"Case-Control Studies: Design, Conduct, Analysis","author":"Schlesselman","year":"1982"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2758870\/jamacardiology_yu_2020_oi_190099_1609877365.47646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T06:03:01Z","timestamp":1610258581000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2758870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2019.5586","relation":{},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}